FDA and CDC Identified bacterial and/or fungal contamination in unopened vials of betamethasone, cardioplegia, and triamcinolone solutions distributed and recalled from NECC. NOT Custodiol HTK

http://www.fda.gov/Drugs/DrugSafety/FungalMeningitis/default.htm

CDC and FDA Laboratory-Confirmed Organisms from Product Samples
Laboratory-Confirmed Organisms from Product Samples Associated with
NECC Recalled Lots of Betamethasone, Cardioplegia, and Triamcinolone Solutions

Medication Lot Number Bacterial and Fungal Contamination
Betamethasone
6 mg/mL injectable –5 mL per vial 08202012@141 Paenibacillus pabuli/amolyticus, Bacillus idriensis, Bacillus flexus, Bacillus simplex, Lysinibacillus sp., Bacillus niacini, Kocuria rosea,
Bacillus lentus
Betamethasone
6 mg/mL injectable –5 mL per vial 07032012@22 Bacillus niabensis, Bacillus circulans
Betamethasone
12 mg/mL injectable – 5 mL per vial 07302012@52 Bacillus lentus, Bacillus circulans, Bacillus niabensis, Paenibacillus barengoltzii/timonensis
Betamethasone
6mg/mL injectable – 5 mL per vial 08202012@44 Bacillus lentus, Bacillus firmus, Bacillus pumilus
Betamethasone
6 mg/mL injectable – 5 mL per vial 08152012@84 Penicillium sp., Cladosporium sp.

Triamcinolone
40mg/mL injectable – 1 mL per vial 06062012@6 Bacillus lentus, Bacillus circulans, Bacillus niabensis, Bacillus nealsonii, Bacillus subtilis group, Bacillus firmus
Triamcinolone
40 mg/mL injectable – 2 mL per vial 08172012@60 Aspergillus tubingensis, Penicillium sp.
Triamcinolone
40mg/mL injectable – 10 mL per vial 08242012@2 Aspergillus fumigatus
Cardioplegia solution
265.5 mL per bag 09242012@55 Bacillus halmapalus/horikoshii, Brevibacillus choshinensis

Leave a Reply

Your email address will not be published. Required fields are marked *